CXCL8 and neoplasm: Co-administration of IL-8 with AdCre was tested in this study to determine whether this chemoattractant could enhance tumor development [IL-8 may increase AdCre entry through the apical membrane of epithelial cells (Lutschg et al., 2011; Kotha et al., 2015)].